SOD2 and breast cancer: In vivo and in vitro studies demonstrated Nrf2-driven MnSOD upregulation postulated from degradation of Caveolin-1 resulted in enhanced cell survival, metastasis, and drug resistance in circulating breast cancer cells (39, 40).